lead in Biological Technology

Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals' Lead Antibody

REDWOOD CITY, Calif.,, Aug. 6 /PRNewswire/ -- OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel antibody therapeutics that target cancer stem cells, today announced the publication in Cell Stem Cell of data demonstrating potent anti-cancer activity in colon ...

PDI Appoints Gerald P. Belle as Lead Independent Director

SADDLE RIVER, N.J., July 30 /PRNewswire-FirstCall/ -- PDI, Inc. (Nasdaq: PDII ), a leading provider of sales and marketing support to U.S. pharmaceutical companies, announced today that current PDI director Gerald P. Belle has been appointed to the newly-established position of lead indepen...

Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector, Reveals Frost & Sullivan

MUMBAI, July 24 /PRNewswire/ -- - Frost & Sullivan's Food & Beverage Focus 2009 Annual Executive MindXchange on Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector The Indian food processing industry has seen some spectacular product devel...

Anthony Hess to Lead SAIC Health Solutions Business Unit

SAN DIEGO and MCLEAN, Va., July 16 /PRNewswire-FirstCall/ -- Science Applications International Corporation (NYSE: SAI ) announced today that Anthony Hess, Ph.D., will be appointed as business unit (BU) general manager of SAIC's Health Solutions BU (HSBU) effective Aug. 3. Hess ...

ClearTrial Selected to Lead Executive Panel from Pharmaceutical and Service Provider Companies at ExL Conference

Kelly Larrabee, Director, Clinical Services, will lead a panel of life sciences executives on the topic of "Capitalizing on Trends in Negotiation, Contracts, and Risk and Reward." Discussion will center around risk/reward approaches and technology collaboration among clinical trial spo...

Lixte Biotechnology Holdings' Lead Compound, LB-1.2, Enhances the Effectiveness of Standard Cancer Chemotherapy in Animal Models

EAST SETAUKET, N.Y., July 2 /PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings (OTC Bulletin Board: LIXT) announced today that investigators of the National Institute of Neurological Disorders and Stroke (NINDS) and the National Cancer Institute (NCI), National Institutes of Health and Lixte r...

ClearTrial Industry Expert to Lead Session at DIA Annual Meeting on Improving Accrual and Contract Management in Clinical Trials

Panel of leading biopharma executives will discuss how Earned Value Management can improve control over clinical development costs, payments, and accruals and facilitate compliance with Sarbanes-Oxley at the DIA 45th Annual Meeting in San Diego. Chicago, IL (PRWEB) June...

BioStorage Technologies Takes Lead Sponsorship Role of 2nd Annual IIR Biorepositories Conference

INDIANAPOLIS, June 11 /PRNewswire/ -- BioStorage Technologies, Inc., a worldwide provider of long- and short-term storage of biomaterials, sample management and cold chain logistics, announced it will participate in the Institute for International Research (IIR) 2nd Annual Biorepositories Conferen...

NovImmune Completes CHF 62.5 (USD 54.8) Million Equity Financing to Move Portfolio Forward and Reacquire Product Rights to Lead Antibodies

PLAN-LES-OUATES, Switzerland, May 12 /PRNewswire/ -- NovImmune, an immunology-focused biotech company dedicated to the development of therapeutic monoclonal antibodies, announced today that it has raised CHF 62.5 million (USD 54.8 million) to take back control of its lead compounds (NI-0401 an...

Ancient diatoms lead to new technology for solar energy

CORVALLIS, Ore. Engineers at Oregon State University have discovered a way to use an ancient life form to create one of the newest technologies for solar energy, in systems that may be surprisingly simple to build compared to existing silicon-based solar cells. The secret: diatoms. These ti...

Putting the squeeze on an old material could lead to 'instant on' electronic memory

The technology of storing electronic information from old cassette tapes to shiny laptop computers has been a major force in the electronics industry for decades. Low-power, high-efficiency electronic memory could be the long-term result of collaborative research led by Cornell materials scie...

MIT: New method could lead to narrower chip patterns

CAMBRIDGE, Mass.--Researchers at MIT have found a novel method for etching extremely narrow lines on a microchip, using a material that can be switched from transparent to opaque, and vice versa, just by exposing it to certain wavelengths of light. Such materials are not new, but the researcher...

MIT: New material could lead to faster chips

CAMBRIDGE, Mass.--New research findings at MIT could lead to microchips that operate at much higher speeds than is possible with today's standard silicon chips, leading to cell phones and other communications systems that can transmit data much faster. The key to the superfast chips is the use ...

Cardiorobotics Announces New CEO, PLSG Executive-in-Residence to Lead Company

PITTSBURGH, March 17 /PRNewswire/ -- Cardiorobotics, Inc., a medical device company developing advanced robotic technologies for use in a wide range of applications, including: medical, industrial, military, and law enforcement, announces the appointment of Dr. Samuel Straface in the position of...

Magellan to Receive Frost & Sullivan 2009 North American Product Innovation Award; Three-Minute LeadCare(R) II Test Identifies Children with Lead Poisoning

CHELMSFORD, Mass., March 17 /PRNewswire/ -- Magellan Biosciences, an emerging leader in systems for clinical-diagnostics, will receive the Frost & Sullivan 2009 North American Product Innovation Award for LeadCare II, a rapid, point-of-care test that enables children and adults to be screened ...

Greater Houston Partnership to Lead Energy Security Discussion

Some of the world's most respected energy experts will be exploring answers to energy security questions during a daylong gathering in Houston, the Energy Capital of the World, as the Greater Houston Partnership once again takes center stage in leading the dialogue on energy policy by hosting &qu...

USAID Selects Abt Associates to Lead Team in Strengthening Mexico Private Sector Competitiveness

CAMBRIDGE, Mass., March 11 /PRNewswire/ -- Abt Associates announced it has been awarded a 5-year, $17.8 million contract from the United States Agency for International Development (USAID) to lead a team of organizations in improving private sector competitiveness while protecting biodiversity in ...

FDA Provides A Positive Review of InNexus Biotechnology Development Plan for Lead Product

- Agency Supports Company's Production and Clinical and Preclinical Plans for DXL625 - - Live Teleconference Scheduled with Leadership and Scientific Team for March 04, 2009 - BRITISH COLUMBIA, Canada March 3 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc. (Toronto Stock Exchange: ...

VIA Pharmaceuticals Announces Grant of New Patent on Lead Compound VIA-2291

SAN FRANCISCO, Feb. 25 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today announced the issuance of United States Patent No. 7,495,024 entitled "Phen...

Genetic discovery could lead to advances in dental treatment

CORVALLIS, Ore. Researchers have identified the gene that ultimately controls the production of tooth enamel, a significant advance that could some day lead to the repair of damaged enamel, a new concept in cavity prevention, and restoration or even the production of replacement teeth. The gen...

ClearTrial Selected to Lead Industry Panel on Managing Clinical Trial Cash Flow and Accruals at CBI Conference

Kristin Lucas, ClearTrial Senior Director of Clinical Services, will lead a panel of top pharmaceutical financial experts in discussing "Methodologies for Managing Cash Flow and Accruals" at the CBI Forecasting & Budgeting conference. The panel will demonstrate practical ways to ga...

Albemarle Manufactures Zymes' PTS, the Lead Compound in a Breakthrough Solubilization Technology

Scale-up of Zymes' PTS by Albemarle responds to the demand in food, beverage and nutritional markets BATON ROUGE, La., Jan. 27 /PRNewswire-FirstCall/ -- Leading specialty chemical company, Albemarle Corporation, (NYSE: ALB ) and innovative bioscience company, Zymes LLC, have joined forces t...

Octapharma Names Dennis D. Curtin To Lead U.S. Plasma Operations

ATLANTA and LACHEN, Switzerland, Dec. 4 /PRNewswire/ -- Octapharma Chairman Wolfgang Marguerre today announced that Dennis D. Curtin has been selected to lead Octapharma's plasma operations in the United States. Curtin had been Octapharma's U.S. legal counsel since 2002 and will now serve as Presi...

Kiadis Pharma Announces Continued Collaboration With Professor Velardi on its Lead Product ATIR(TM)

AMSTERDAM, Nov. 28 /PRNewswire/ -- Oncology focused biopharmaceutical company Kiadis Pharma announces today that Andrea Velardi, M.D., Professor of Clinical Immunology at the University of Perugia, Italy and Kiadis Pharma are continuing their collaboration on ATIR(TM), a product in clinical develo...

According to AlphaDetail, Inc. Merck and Tibotec Therapeutics Lead Among Infectious Disease Specialists

SAN MATEO, Calif., Nov. 5 /PRNewswire/ -- In a survey of 100 infectious disease specialists following last week's ICAAC/IDSA Annual Meeting, Merck was perceived as standing out above other companies at the conference, while Tibotec Therapeutics was perceived as having the best overall image in...

William E. Lewandowski to Lead Simbionix US Marketing Team in Simbionix's Strategic Expansion in the US Market

CLEVELAND, Ohio and LOD, Israel, November 3 /PRNewswire/ -- Simbionix USA Corporation (Simbionix), a developer of medical simulators and hands-on curriculum for training medical professionals, today announced that William E. Lewandowski will join the company as the US Marketing Director on Nov...

Glycotex Reports First Patient Enrollment in Phase IIb Study of Lead Product Candidate GLYC-101 for Wound Healing

ROCKVILLE, Md., Oct. 20 /PRNewswire/ -- Glycotex, Inc. today announced enrollment of the first patient in a Phase IIb study evaluating the effect of GLYC-101 on wound closure and cosmetic outcomes in cosmetic surgery patients undergoing carbon dioxide laser skin resurfacing on the lower eyelid...

GeneNews appoints Patrick Terry as lead strategic advisor for U.S. commercialization of ColonSentry(TM)

TORONTO, Oct. 15 /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has appointed Patrick Terry as its lead strategic advisor for the U...

OncoGenex Achieves Key Regulatory Milestone for Lead Product Candidate, OGX-011

FDA confirms appropriateness of durable pain palliation as a primary endpoint for product marketing approval Milestone achievement results in release of escrowed shares BOTHELL, WA and VANCOUVER, Oct. 13 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals Inc. (NASDAQ: O...

Dr. Charles Sanders to Become Lead Director of Epiphany Biosciences

SAN FRANCISCO, Oct. 2 /PRNewswire-FirstCall/ -- Epiphany Biosciences, Inc. announced today that Dr. Charles Sanders has accepted the position of Lead Director. Dr. Sanders is a highly experienced biotechnology and pharmaceutical executive, currently serving as Lead Director of Genentech. He ha...

TorreyPines Therapeutics Strategically Repositions as Development Company Focusing on Three Versatile Lead Compounds

- Plan Includes Shut Down of Discovery Operations and Expansion of Business Development Activities - LA JOLLA, Calif., Sept. 25 /PRNewswire/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX ) today announced that it will transition from a discovery and development company ...

EMEA Grants Kiadis Pharma Lead Product ATIR(TM) Orphan Drug Designation

AMSTERDAM, September 22 /PRNewswire/ -- Kiadis Pharma announced today that its lead product ATIR(TM) has been granted orphan drug designation (ODD) by the European Medicines Agency (EMEA) for the prevention of acute Graft versus Host Disease (GvHD) following an allogeneic bone marrow transplan...

Trillium secures additional financing on the strength of lead program and proprietary position around the CD200 immunoregulatory pathway

TORONTO, Sept. 18 /PRNewswire/ - Trillium Therapeutics Inc., a privately-held biopharmaceutical company specializing in the development of innovative therapies for the treatment of immune-mediated disorders, announced today that it has secured $12 million in new financing from its existing inv...

Epeius Biotechnologies' Lead Product, Rexin-G for Metastatic Cancer, Aptly Highlighted by National Cancer Institute Journal

SAN MARINO, Calif., Sept. 15 /PRNewswire/ -- Epeius Biotechnologies Corporation today announced that Rexin-G, its lead product in development for metastatic cancer, has been highlighted in a recent NEWS article published by the Journal of the National Cancer Institute (JNCI, Sept. 9, 2008). Th...

Ardea Biosciences to Present Data on Lead MEK inhibitor, RDEA119, at EORTC-NCI-AACR Symposium

SAN DIEGO, Sept. 11 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA ) today announced that preclinical data will be presented on the Company's lead mitogen-activated ERK kinase (MEK) inhibitor, RDEA119, at the 20th European Organisation for Research and Treatment of Cancer (EO...

ESBATech Announces Successful Completion of Phase I Clinical Study for Lead Antibody Fragment in Ophthalmic Indications

Preclinical Pharmacokinetic Data to be Presented at the 7th International Symposium on Uveitis in Germany ZURICH, Switzerland, Sept. 8 /PRNewswire/ -- ESBATech AG, a leading developer of antibody fragment therapeutics, today announced that the company has successfully complet...

BioMS Medical's lead drug, dirucotide (MBP8298) for the treatment of multiple sclerosis, receives fast track designation from FDA

Toronto Stock Exchange Symbol: MS EDMONTON, Sept. 4 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that the Food and Drug Administration (FDA) of the United States has granted fast track designation for...

CoreValve Successfully Treats the First Pacific Rim Patients with Its ReValving System for Percutaneous Aortic Valve Replacement : Australia/New Zealand Regulatory-Cleared Evaluation Registry is Expected to Lead to Market Clearance for These Countries

CoreValve ( www.corevalve.com ) announced today that an Australia/New Zealand-focused clinical evaluation of its proprietary percutaneous ReValving System, which features a porcine pericardium valve mounted in a self-expanding frame, was initiated last week. IRVINE, Ca...

FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals' Lead Product Candidate OGX-011

BOTHELL, WA and VANCOUVER, Aug. 22 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals (NASDAQ: OGXI ) announced today that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive meta...

Ardea to Present Data on Lead HIV Candidate, RDEA806, at ICAAC/IDSA Joint Meeting

SAN DIEGO, July 28 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA ) today announced that data will be presented on RDEA806, the Company's novel investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) for patients with human immunodeficiency virus (HIV) at the 4...